CLGN
CollPlant Biotechnologies LtdCompany with tickers: CLGN
CIK
1631487
CUSIP
M2R51X116
Shares Outstanding
14,423,253
13F Activity (30d)
15 filings
13 filers
Total shares sold short and not yet covered, reported to FINRA by broker-dealers and published twice a month (bi-monthly). Days to cover divides the short position by average daily volume; a high value (above 5) can signal short-squeeze potential.
Short Squeeze Score
20/100
Short interest 0.3% of shares — P28
Days to cover 1.1 — P30
Short-volume trend -25.1% — P4
Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-05-29). Equal-weight mean of the available factors.
Short Interest History
| Settlement Date | Current Position | Previous Position | Change | Days to Cover |
|---|---|---|---|---|
| 2026-05-29 | 42,484 | 84,316 | -41,832 | 1.10 |
| 2026-05-15 | 84,316 | 80,466 | +3,850 | 2.19 |
| 2026-04-30 | 80,466 | 65,694 | +14,772 | 1.00 |
| 2026-04-15 | 65,694 | 62,082 | +3,612 | 1.00 |
| 2026-03-31 | 62,082 | 68,335 | -6,253 | 1.82 |
| 2026-03-13 | 68,335 | 75,852 | -7,517 | 2.25 |
| 2026-02-27 | 75,852 | 112,739 | -36,887 | 1.00 |
| 2026-02-13 | 112,739 | 110,193 | +2,546 | 1.00 |
| 2026-01-30 | 110,193 | 79,771 | +30,422 | 3.76 |
| 2026-01-15 | 79,771 | 61,080 | +18,691 | 6.06 |
| 2025-12-31 | 61,080 | 37,710 | +23,370 | 1.23 |
| 2025-12-15 | 37,710 | 90,425 | -52,715 | 1.51 |
| 2025-11-28 | 90,425 | 121,057 | -30,632 | 4.81 |
| 2025-11-14 | 121,057 | 125,645 | -4,588 | 6.03 |
| 2025-10-31 | 125,645 | 170,503 | -44,858 | 3.08 |
| 2025-10-15 | 170,503 | 48,157 | +122,346 | 3.56 |
| 2025-09-30 | 48,157 | 36,343 | +11,814 | 1.00 |
| 2025-09-15 | 36,343 | 41,626 | -5,283 | 3.58 |
| 2025-08-29 | 41,626 | 63,706 | -22,080 | 1.00 |
| 2025-08-15 | 63,706 | 107,818 | -44,112 | 1.66 |
| 2025-07-31 | 107,818 | 126,054 | -18,236 | 2.10 |
| 2025-07-15 | 126,054 | 86,603 | +39,451 | 1.63 |
| 2025-06-30 | 86,603 | 79,263 | +7,340 | 1.00 |
| 2025-06-13 | 79,263 | 166,381 | -87,118 | 1.00 |
Showing 1–24 of 24 settlements